BPD Biologics Process Development Conference Banner
← Back to News
Industry News2026/08/21

High demand for pharmaceutical partnerships in Indonesia, Malaysia, and Singapore! The 2026BPD Singapore Meeting System is launching soon.

Southeast Asia Biopharmaceutical MarketAt a critical juncture of rapid growth and deep integration.SingaporeAligning HSA's regulatory framework with the FDA and continuous expansion of Tuas Park have made it one of the preferred locations for MNC regional headquarters.IndonesiaLeverage the strategic market growth driven by 2.7 billion in population dividends and BPOM regulatory reforms to commercialize innovative drugs.ThailandEEC policies are driving the rise of bio-manufacturing capacity; Malaysia is leveraging its cost advantages to capture regional CDMO demand...

Yet behind the booming opportunities lie structural challenges in matching:

The real challenge in the Southeast Asian biopharma market has never been "whether there is demand," but ratherEfficient matching across diverse marketsPain points such as fragmented multi-agency oversight, misalignment between research and production standards, and scattered information silos hinder precise matchmaking. Traditional exhibitions struggle to reach decision-makers, while cross-border travel further reduces efficiency.

BPD Singapore: Precision Breakthrough

2026BPD Singapore Biopharmaceutical Process Development ConferenceComing soon9 22-23Login to LionCity, focusing on manufacturing capacity cooperation, market access, and regional compliance between Southeast Asia and China. Bridge Chinese pharmaceutical companies, suppliers, and Southeast Asian partners to seize the strategic window for expansion into Southeast Asia.

BPD will launch its appointment system in Singapore for the first time.via pre-approval"1-on-1 + 30min"Meeting Consultation ModeDirect Link Requirements and ResourcesEfficient face-to-face meetings on-site drive substantive collaborations, enhancing your brand image and streamlining business connections.

Currently,A growing number of domestic and international biopharmaceutical companies and research institutions have joined the appointment system., participants includeC-Level ExecutivesTechnical LeadandAcademic Leader, covering the entire industrial chain from business development, preclinical R&D, regulatory affairs, to production operations, has been releasedBD, Financing, Technical Collaboration & Project ExchangeWait for a confirmed appointment request.

Precise appointment demand release

Currently, disclosing intent to collaborate in 2026BPD Singapore:Head of Procurement, Singapore RegionFocus on API quality compliance; seek testing services and regional supply chain partners.Leading Malaysian injectable pharmaceutical companyWith its own production base, we seek CDMO and formulation process service providers for collaboration on filling operations and formulation development.Singapore National Research InstituteFocusing on cutting-edge bioprocess R&D, we seek partners for mass spectrometers, sequencing services, biochemical reagents, and joint development.Large Malaysian Pharmaceutical CompanyUnlock millions of dollars in procurement demand: seeking long-term partnerships for cell culture consumables, API active pharmaceutical ingredients, and testing services...

Appointment system launching soon

2026BPD Singapore 1V1 Appointment System opens on 24 (8), and limited-time offer ends soon!Every booking slot is an opportunity to break through Southeast Asia's information barriers and connect with core regional resources. Slots are limited.Lock 1v1 chat for 30 minutes before the meetingCooperation opportunities go to those who act first!Register now to secure your spot for Singapore's key conversations in 9!

  • BD Partnership:License-in/out, joint R&D, technology acquisition...

  • Investment & Financing Matchmaking:Connect directly with investment firms specializing in the biopharmaceutical sector...

  • Procurement Partnership:Supply chain procurement integration, supplier onboarding and evaluation...

  • Long-term supply chain partnership:CDMO/CMO capacity collaboration, regional supply chain layout...

  • Market Access:Drug registration, commercialization pathways, and distribution network integration across Southeast Asian countries...

Share to:

Related Articles

Suzhou Biopharmaceutical Special Mother Fund Announcement: Plans to Invest in and Deploy "AI + Biotechnology"

Read more →

Unmissable perks: Claim free gifts on-site! 2026BPD Sign in early in Shanghai to unlock exclusive rewards. 0-ticket registration ends in 9 days.

Read more →

Register for the BPD Biologics Process Development Conference

Connect with industry leaders and explore the frontiers of biopharmaceutical process innovation

Sign Up Now